Objective: Coronaviruses and paramyxoviruses, both of which are RNA viruses, have similar structural glycoprotein characteristics. It is considered that antibodies developed against these structures may protect by cross-reaction because the glycoproteins of viruses are related to their ability to infect the cell.
Methods:In the present study, the clinical course of patients who were hospitalized with the diagnosis of COVID-19 and found to be positive for PCR, and whether they were affected by Measles immunity was evaluated.Results: A total of 56 (34.5%) of 162 patients who had a mean age of 50 with at least one comorbid disease and 41 (25.4%) of them were followed up in the Intensive Care Unit and 15 (9.3%) patients died. Measles IgG was positive in 148 (91.3%) of the patients. No statistically significant differences were detected between the Measles IgG values of the patients hospitalized in the Intensive Care Unit and the ward (p=0.41). Similarly, no significant differences were detected between the Measles IgG values of the patients who died and those who were discharged (p=0.60). ROC analysis revealed that IgG values did not have a cut-off value to predict mortality (AUC=0.542, p=0.53). In the Logistic Regression Analysis made for independent predictors of mortality, it was found that each increase in age increased mortality by 10% (OR: 1.1, 95% CI: 0.05-1.16, p<0.001), and the presence of pneumonia was a risk factor for mortality.
Conclusion:No relationship was detected between vaccination against Measles or the presence of antibodies in the prognosis of COVID-19 infection.